Abstract

Shortly after the discovery of the cytostatic activity of cis-diamminedichloroplatinum(II) (cisplatin) (1) it was suggested that the mechanism of antitumor activity of cisplatin involves its binding to DNA (for review, see refs. 2–4). In addition, it was suggested that the mechanism of antitumor activity of cisplatin might be analogous to the biologic activity of bifunctional alkylating agents (such as nitrogen mustard), which also exhibit cytostatic effects (5). As the cytostatic effect of di-alkylating agents was generally accepted to be associated with their DNA interstrand crosslinking efficiency, the first hypotheses on the mechanism underlying the cytotoxicity of cisplatin in tumor cells were derived from its ability to form interstrand crosslinks in DNA (6). On the basis of this analogy, cisplatin was sometimes incorrectly called an “alkylating agent.”

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.